About Us

Management Team

McCoy Moretz, M.D., CEO/CMO/Director
McCoy Moretz, MD has been Chief Executive Officer, Chief Medical Officer, Director, Founder and on the advisory board of multiple biopharmaceutical and medical device companies such as HypGen, Inc, Ermis Labs, LED Technologies, LLC, Kathy Ireland World Wide, Inc., Torri Labs, Equalizer, LLC, b:You Marketing Group, and Rich Pharmaceuticals, Inc. Dr. Moretz has numerous world-wide speaking engagements, has publications and patents, and has more than 30 years of medical and life-science experience. He is an award winning Board Certified Surgeon with multiple certifications. He has earned a degree in Doctor of Medicine from Medical College of Georgia in Augusta, Georgia.

Professor Richard L. Chang, Inventor/CSO
Inventor and patent holder of multiple indications. He has authored 122 peer-reviewed journal publications; has filed multiple significant patents for the treatment of cancer, Infectious disease, hematology and neurological disorders; and has presented over 150 scientific abstracts. Prof. Chang has over 50 years of research experience with such companies as Hoffman-La-Roche, Schering Corp and Burroughs Wellcome and a full professor and director of Research at Rutgers University. He successfully launched and completed off IND and IND phase I trials in China and US.

Ben Chang, President/CFO/Chairman
Mr. Ben Chang has previously been founder, director, CEO, President, CFO and/or COO of such biotech companies as Biosuccess Biotech Co. LTD., Rich Pharmaceuticals, Inc., and HypGen, Inc. Mr. Chang started his life-science career as the founder and managing partner of Sun-Rich Chemicals, a product development and distribution organization for nutraceuticals. Mr. Chang has over 26 years of pharmaceutical and executive level experience. Mr. Chang also has experience in international banking, venture capital, M&A, finance, go-public transactions and organizational design and operations. Mr. Chang has a Bachelor of Science Degree in Economics from East Carolina University where he focused on accounting and international business.

Isis Luna, Chief Operating Officer
Ms. Luna has 11 years of experience in management starting her professional career within philanthropic organizations, along side the Roosevelt family. Shortly after, she stepped up to executive officer in multiple biopharmaceutical companies, using her skills in organization and knowledge in business operations and management. For the last 6 years she served as Chief Operating Officer at Rich Pharmaceuticals, Inc. and HypGen Inc. biotech company. Isis graduated with a Bachelor of Arts degree from University of Florida.

Steven J. Davis, ESQ, Legal Councel
Mr. Davis has over 27 years experience in corporate and business law. His experience ranges from serving  on the Board of Directors of Philter Labs, Inc., and on the Board of Directors and Audit, Compensation and Nominating Committees of Telanetix, Inc. Prior to starting his own practice, Mr. Davis served as General Counsel and an executive officer of Molecular Imaging Corporation, and as in-house counsel for Leap Wireless International, Inc. He also practiced in the Business and Corporate Group in the San Diego office of Luce, Forward, Hamilton & Scripps LLP (now Dentons), a full-service law firm with over 200 attorneys, where he advised both private and public clients. Mr. Davis is licensed to practice law in California, the District of Columbia, and Minnesota. He received his Juris Doctor, Cum Laude, from the University of San Diego, School of Law in 1992. He received his B.A. in Political Science, Cum Laude, from Arizona State University in 1988.

Annette George, Clinical Director
Annette has regulatory, clinical operations and trial management expertise with 20 years of experience in a wide range of different segments of the drug development process in the industry. Her experience ranges from international pharmaceutical to Clinical Research Organization and biotechnology companies. She has extensive experience in carrying out and managing preclinical and Phase 1~3 clinical trials focused on oncology and hematology. Annette has a Master of Science degree in Biochemistry.

Joseph Huffman, CPA, Finance Director
Joseph has been in the finance and accounting industries for 32 years.  His experience ranges from a commercial lending Vice President to managing partner at Huffman & Huffman LLC CPA’s since 1998.  He has been a CPA for 28 years and has served as a Finance Director in biotechnology for over 13 of those years. Joseph has a Master of Science degree in accounting.

Advisory Board

Professor Renping Zhou
Mr. Zhou is the current Chairperson and Professor in the Department of Chemical Biology at Rutgers University in New Jersey. He has 36 years of experience in cancer research, has been awarded multiple grants and has 62 peer reviewed publications.

Professor Xi Zheng
Mr. Zheng currently holds the positions of Director, Research Professor, Unilever Chair and Associate member at Rutgers Cancer Institute of New Jersey. He has 37 years of experience in cell biology, cancer research, immunohistochemistry and immunocytochemistry. He holds 5 patents and inventions in cancer, and has 102 peer reviewed publications.

Sean M. O’Connell, Ph.D
Mr. O’Connell has over 25 years of experience as Director, Medical Director, Chief Operating Officer, Chief Medical Officer, Medical Director, Clinical Research Manager, and VP & SVP of Medical Affaires. He has 26 peer reviewed publications and 38 abstracts and speaking engagements.

Professor Harold H. Lee
Professor Lee has more than 20 peer-review science papers in developmental biology and biotechnology. He holds 4 patents in biotechnology. He is also an author of 4 novels.